Plaque Progression Differences Between Apixaban and Rivaroxaban in Patients With Atrial Fibrillation Measured With Cardiac Computed Tomography and Plaque Quantification

By sjmartinez • February 3, 2023

Aldana-Bitar J, Moore J, Manubolu VS, Dahal S, Verghese D, Lakshmanan S, Hussein L, Crabtree T, Jonas R, Min JK, Earls JP, Budoff MJ. Plaque Progression Differences Between Apixaban and Rivaroxaban in Patients With Atrial Fibrillation Measured With Cardiac Computed Tomography and Plaque Quantification. Am J Ther. 2022 Oct 18. doi: 10.1097/MJT.0000000000001569. Epub ahead of print. PMID: 36731003.

Tags: Cardiology/Epi, Publications

Long-Term Survival in Liver Transplant Patients With Coronary Artery Disease: A Multi-Institutional Study

Wray CL, Scovotti JC, Tobis J, Honda HM, Planinsic R, Walia A, Findlay J, Wagener G, Cywinski JB, Olmos A, Markovic D, Hughes C, Humar[...]

Psychological and emotional drivers of atherosclerotic cardiovascular disease: Screening the brain to protect the heart

Atmani K, Vaseghi M. Psychological and emotional drivers of atherosclerotic cardiovascular disease: Screening the brain to protect the heart. Trends Cardiovasc Med. 2025 Nov 4:S1050-1738(25)00145-8.[...]

Cardiac resynchronisation therapy among adults with a systemic right ventricle: a multicentre experience

Fusco F, Scognamiglio G, Dellborg M, Dehghani P, Jameson SM, Kay WA, Cramer JW, Vonder Muhll I, Krieger EV, Rodriguez FH, Burchill LJ, Nicolarsen J,[...]